UK: +44 (0)1223 264428
USA: +1 (650) 798 5134
Technology and product design firm Cambridge Design Partnership (CDP) has announced the appointment of drug delivery industry veteran Bastiaan de Leeuw as it embarks on a new phase of growth in the sector. As head of drug delivery business development, he will be driving CDP’s expansion into new markets around the world.
Bastiaan will be working alongside CDP partner and head of drug delivery Uri Baruch, who has overseen huge growth in the sector over the past five years. Uri’s drug delivery team has delivered a variety of projects – ranging from an award-winning needle safety device and an emergency auto-injector to pen injector packaging designs for drug delivery devices and inhalation products – including successful regulatory submissions in both the US and Europe.
“I am delighted to welcome Bastiaan to our growing world-class team,” said Uri. “He has a wealth of knowledge and experience of the industry that will be invaluable as we continue our record-breaking growth.”
In his long and diverse career, Bastiaan has held a string of senior posts in organisations such as Cambridge device design and development company Oval Medical Technologies and medical device development and manufacturing firm Bespak. He has particular expertise in combination products – but has also spent five years working in diagnostics as CEO of molecular diagnostic research and service company NovioGendix, now part of multinational healthcare company MDxHealth. He has a degree in biopharmaceutical sciences from Leiden University in the Netherlands.
“I am excited to be joining the CDP team at such an interesting time, as the drug delivery group continues its phenomenal growth,” said Bastiaan. “I am looking forward to bringing together the varied strands of my healthcare career to help clients around the world translate opportunities and challenges into real-life drug delivery devices for the benefit of patients.”
Using smart packaging to support consumer trials
A novel approach to drug delivery to improve adherence and the patient experience
Stay up to date with all our work and our latest news by signing up to our newsletter.